trending Market Intelligence /marketintelligence/en/news-insights/trending/f2AW7wLbpmfYCq3Ii_0TcQ2 content esgSubNav
In This List

Aphria closes acquisition of Germany's CC Pharma

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Aphria closes acquisition of Germany's CC Pharma

Canadian cannabis company Aphria Inc. completed its previously announced acquisition of Germany-based pharmaceutical distributor CC Pharma GmbH.

Upon closing, former CC Pharma shareholders were paid with €18.9 million cash. They may also receive up to €23.5 million after closing if certain performance milestones are met.

The acquisition is part of Aphria's expansion efforts in Germany and to ultimately establish a pan-European platform incorporating demand, supply and distribution.